MACRO GROUP PHARMACEUTICALS (MACRO CAPITAL) S.A.E |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2 EGP | +0.50% |
|
-0.50% | -32.20% |
| Sales 2022 | 730M 15.21M 20.82M | Sales 2023 | 526M 10.96M 15.01M | Capitalization | 1.68B 35.06M 47.99M |
|---|---|---|---|---|---|
| Net income 2022 | 174M 3.63M 4.96M | Net income 2023 | -273M -5.69M -7.79M | EV / Sales 2022 | 2.59 x |
| Net Debt 2022 | 16.96M 353K 484K | Net Debt 2023 | 151M 3.14M 4.3M | EV / Sales 2023 | 3.48 x |
| P/E ratio 2022 |
10.9
x | P/E ratio 2023 |
-6.1
x | Employees | - |
| Yield 2022 |
3.25% | Yield 2023 |
-
| Free-Float | 27.02% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.50% | ||
| 1 week | -0.50% | ||
| Current month | -4.76% | ||
| 1 month | -6.10% | ||
| 3 months | -23.37% | ||
| 6 months | -33.33% | ||
| Current year | -32.20% |
1 week
1.98
2.08
1 month
1.912.24
Current year
1.913.84
1 year
1.913.84
3 years
1.915.28
5 years
1.915.28
10 years
1.915.28
| Managers | Title | Age | Since |
|---|---|---|---|
Hisham Wasfy
CEO | Chief Executive Officer | - | 19-11-30 |
Ashraf Hamdy
DFI | Director of Finance/CFO | - | 19-06-30 |
Zeina Shahin
IRC | Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Sahar El-Sallab
BRD | Director/Board Member | - | 20-12-31 |
Ahmed Badreldin
BRD | Director/Board Member | 52 | 20-12-31 |
Ahmed El-Nayeb
FOU | Founder | - | 01-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-27 | 2 | +0.50% | 4,740,933 |
| 24-06-26 | 1.99 | -0.50% | 1,344,226 |
| 24-06-25 | 2 | 0.00% | 1,422,397 |
| 24-06-24 | 2 | -0.99% | 3,109,108 |
End-of-day quote Egyptian Exchange, June 26, 2024
More quotes
Macro Group Pharmaceutical S.A.E. (Macro Capital) is specialized in developing, manufacturing and marketing pharmaceuticals. The company's products include anti-scar, skincare, antiseptic, hair care, oral care and muscle relaxant medicines. In addition, the group offers plant-based medicines.
At the end of 2021, Macro Group Pharmaceutical S.A.E. (Macro Capital) had one production site in Egypt.
Sector
Pharmaceuticals
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2
EGP
Average target price
5.3
EGP
Spread / Average Target
+165.00%
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -32.20% | 23.45M | |
| +55.95% | 819B | |
| +43.36% | 638B | |
| -6.98% | 351B | |
| +19.08% | 329B | |
| +9.05% | 298B | |
| +17.06% | 242B | |
| +2.99% | 225B | |
| +13.33% | 217B | |
| +8.91% | 168B |
- Stock Market
- Equities
- MCRO Stock
